全文获取类型
收费全文 | 70714篇 |
免费 | 6504篇 |
国内免费 | 3733篇 |
专业分类
耳鼻咽喉 | 961篇 |
儿科学 | 1079篇 |
妇产科学 | 879篇 |
基础医学 | 8137篇 |
口腔科学 | 1511篇 |
临床医学 | 8284篇 |
内科学 | 10528篇 |
皮肤病学 | 1053篇 |
神经病学 | 3788篇 |
特种医学 | 2461篇 |
外国民族医学 | 28篇 |
外科学 | 7885篇 |
综合类 | 11818篇 |
现状与发展 | 11篇 |
一般理论 | 21篇 |
预防医学 | 4821篇 |
眼科学 | 2129篇 |
药学 | 6495篇 |
61篇 | |
中国医学 | 3656篇 |
肿瘤学 | 5345篇 |
出版年
2024年 | 157篇 |
2023年 | 841篇 |
2022年 | 1903篇 |
2021年 | 3035篇 |
2020年 | 2372篇 |
2019年 | 2099篇 |
2018年 | 2217篇 |
2017年 | 2076篇 |
2016年 | 1968篇 |
2015年 | 2980篇 |
2014年 | 3752篇 |
2013年 | 3817篇 |
2012年 | 5536篇 |
2011年 | 5788篇 |
2010年 | 3819篇 |
2009年 | 3355篇 |
2008年 | 4180篇 |
2007年 | 4239篇 |
2006年 | 3947篇 |
2005年 | 3751篇 |
2004年 | 2611篇 |
2003年 | 2421篇 |
2002年 | 2080篇 |
2001年 | 1698篇 |
2000年 | 1606篇 |
1999年 | 1410篇 |
1998年 | 788篇 |
1997年 | 718篇 |
1996年 | 565篇 |
1995年 | 532篇 |
1994年 | 446篇 |
1993年 | 290篇 |
1992年 | 445篇 |
1991年 | 393篇 |
1990年 | 372篇 |
1989年 | 345篇 |
1988年 | 299篇 |
1987年 | 275篇 |
1986年 | 263篇 |
1985年 | 193篇 |
1984年 | 148篇 |
1983年 | 107篇 |
1982年 | 69篇 |
1981年 | 76篇 |
1979年 | 107篇 |
1977年 | 67篇 |
1976年 | 67篇 |
1974年 | 84篇 |
1973年 | 72篇 |
1972年 | 79篇 |
排序方式: 共有10000条查询结果,搜索用时 800 毫秒
71.
Clinical experience of phototherapy for non-haemolytic hyperbilirubinaemia in 3999 infants in Kandang Kerbau Hospital, Singapore, is documented. Phototherapy was most effective in extremely preterm infants with very low birth weight (gestation less than or equal to 32 weeks, birth weight less than or equal to 1500 g) and least effective in full term infants with very low birth weight (gestation greater than or equal to 37 weeks, birth weight less than or equal to 1500 g) and large preterm infants (gestation less than 37 weeks, birth weight greater than 2270 g). Overall, phototherapy was effective in almost all the infants, with a failure rate of only 2.00/1000 infants. No characteristic features common to all the failures could be detected. The bilirubin rebound was usually mild; repeat phototherapy was required in only 30 infants (7.50/1000), with the response to the second exposure comparable to that to the first. No infant required a third exposure. All the infants tolerated phototherapy well, none developing any illness that could be attributed to the treatment. This clinical experience shows that phototherapy for the treatment of nonhaemolytic hyperbilirubinaemia is effective and safe. 相似文献
72.
Background
A standardised suction technique has been used to sample plasma proteins in dermal interstitial fluid (IF) serially for 5 to 6 days from a suction-induced skin mini-erosion. Increased protein concentrations ascribed to inflammation have been shown from day 1 onward. In this study, we assessed the effect of two different extraction pressures on IF sample composition. 相似文献73.
74.
膳食黑米皮抑制高脂诱导的家兔动脉粥样硬化形成及其机制的初步探讨 总被引:1,自引:0,他引:1
目的 探讨膳食黑米皮对高脂诱导的家兔动脉粥样硬化形成的影响及其作用机制。方法 24只雄性新西兰大耳白家兔,按体重随机分为3组,分别饲以正常基础饲料、高脂饲料(含96%基础饲料、0.5%胆固醇、3.5%猪油)、黑米皮饲料(含 91%基础饲料、0.5%胆固醇、3.5%猪油、5%黑米皮),实验期为 60d。用图像分析法测定各组家兔主动脉脂质斑块面积,并分析家兔氧化与抗氧化状态。结果 黑米皮实验家兔的主动脉壁斑块面积较高脂组低66%(P<0.001);黑米皮组实验家兔的主动脉壁8-ohdG含量和血清及主动脉壁中MDA水平也低于高脂组(P<0.05 );而红细胞及主动脉壁中SOD水平和血清α-生育酚含量在两个处理组之间差异无显著性。结论 膳食黑米皮可以抑制高脂诱导的家兔动脉粥样硬化形成,其机制可能与之降低机体氧化应激水平及过氧化脂质生成有关。 相似文献
75.
芦沙坦和苯那普利对高血压大鼠左室肥厚的抑制作用 总被引:2,自引:0,他引:2
目的:研究芦沙坦及苯那普利对老龄前期自发性高血压大鼠(SHR)左室肥厚及丝裂素活化蛋白激酶(MAPK)的抑制作用。方法:将老龄前期SHR随机分为SHR对照组,苯那普利(10mg.kg^-1.d^-1)及芦沙坦(30mg.kg^-1.d^-1)治疗组,治疗期为3个月,每月测压一次,治疗结束后处死动物,测定心肌肥厚指标、血中及心肌中内皮素(ET)、血管紧张素AⅡ及MAPK。结果:苯那普利及芦沙治疗后血压、心肌肥厚指标、血中及心肌中内皮素(ET)及MAPK明显低于SHR相对照组(P<0.01),芦沙坦组血中及心肌中AⅡ无下降。结论:AⅡ、ET及MAPK参与了SHR的血压升高及心肌肥厚的形成。苯那普利及芦沙坦有抑制AⅡ、ET及MAPK的活性,从而达到降压及逆转心肌肥厚的作用。 相似文献
76.
目的:探讨布一加综合征的诊治经验。方法:回顾分析本院自1993年-2002年,采用超声介入及手术方法治疗48例布加综合征的疗法结果。超声引导下支架术治疗布一加综合征38例,其中内支架术联脾肾分流术治疗5例,支架术联合肠腔分流术治疗8例;腔房人工血管转流术治疗4例,肠腔转流术治疗2例,肠颈转流术治疗2例,经右心房联合破膜2例。结果:随访1个月-9年,平均4.68年,37例获显疗效,2例改善,6例行二次手术治疗,3例死亡。结论:应重视早期诊断和治疗。腔内超声介入方法治疗布一加综合征,简便、准确、安全、疗效肯定;联合分流术解除肝静脉梗阻,可获得满意疗效。 相似文献
77.
目的 :研究肺癌组织中第 3号染色体短臂 (3P)和第 9号染色体短臂 (9P)上微卫星标志物的改变与肺癌发生发展的关系。方法 :应用聚合酶链反应 (PCR)结合微卫星银染法检测 5 6例肺癌和 2 3例良性肺部病变 3P和 9P上的微卫星标志物的改变。结果 :5 6例肺癌组织标本中 3P上有微卫星改变 2 6例 ,检出率 46% ,9P上有微卫星改变的 2 3例 ,检出率为 41% ,5 6例肺癌组织中 ,3P和 9P上有微卫星改变的 3 9例 ,检出率 69 6% ,2 3例肺部良性疾病组织中均未出现微卫星标志物改变。肺癌组织标本中 3P上的微卫星改变与肺癌的分化程度有关 ,低分化肺癌的微卫星改变较高、中分化肺癌的微卫星改变明显增多 (P <0 .0 1)。而 9P上的微卫星改变与淋巴结转移有关 ,有淋巴结转移的肺癌组织标本上微卫星改变较不伴淋巴结转移的微卫星改变检出率明显增多 ,(P <0 .0 5 )。结论 :3P和 9P上的微卫星改变与肺癌发生、发展和转移密切相关 ,检测肺癌组织 3P和 9P上的微卫星改变对肺癌的早期诊断和判断有无淋巴结转移有一定的价值 相似文献
78.
Sherry X Yang Richard M Simon Antoinette R Tan Diana Nguyen Sandra M Swain 《Clinical cancer research》2005,11(17):6226-6232
PURPOSE: To delineate gene expression patterns and profile changes in metastatic tumor biopsies at baseline and 1 month after treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib in patients with metastatic breast cancer. EXPERIMENTAL DESIGN: Patients were treated with 150 mg of oral erlotinib daily. Gene expression profiles were measured with Affymetrix U133A GeneChip and immunohistochemistry was used to validate microarray findings. RESULTS: Estrogen receptor (ER) status by immunohistochemistry is nearly coincided with the two major expression clusters determined by expression of genes using unsupervised hierarchical clustering analysis. One of 10 patients had an EGFR-positive tumor detected by both microarray and immunohistochemistry. In this tumor, tissue inhibitor of metalloproteinases-3 and collagen type 1 alpha 2, which are the EGF-down-regulated growth repressors, were significantly increased by erlotinib. Gene changes in EGFR-negative tumors are those of G-protein-linked and cell surface receptor-linked signaling. Gene ontology comparison analysis pretreatment and posttreatment in EGFR-negative tumors revealed biological process categories that have more genes differentially expressed than expected by chance. Among 495 gene ontology categories, the significant differed gene ontology groups include G-protein-coupled receptor protein signaling (34 genes, P = 0.002) and cell surface receptor-linked signal transduction (74 genes, P = 0.007). CONCLUSIONS: ER status reflects the major difference in gene expression pattern in metastatic breast cancer. Erlotinib had effects on genes of EGFR signaling pathway in the EGFR-positive tumor and on gene ontology biological process categories or genes that have function in signal transduction in EGFR-negative tumors. 相似文献
79.
人肿瘤特异抗原MAGE-3基因疫苗的构建和表达 总被引:8,自引:1,他引:7
目的:克隆肿瘤特异性共享抗原mage-3基因,制备基于α-病毒复制酶的高效黑色素瘤特异性基因疫苗。方法:用RT-PCR方法从黑色素瘤细胞系LB373中制备mage-3基因,以含α-病毒复制酶的哺乳细胞高效表达质粒pSMART2a为载体,构建重组DNA疫苗。重组子用载体中的T7和T3启动子序列为测序引物进行自动测序。再将鉴定过的重组质粒用脂质体法转化293细胞,用免疫印迹法和免疫组化法鉴定转化细胞中mage-3蛋白的表达。结果:正确构建了mage-3/pSMART2a重组质粒,并且在转化此质粒的293细胞中检测出了mage-3蛋白的表达。结论:此重组mage-3/pSMART2a质粒可以作为肿瘤特异的DNA疫苗,可进行下一步的肿瘤动物模型的疫苗接种及相关免疫学效应研究。 相似文献
80.
保留肾单位手术治疗早期小肾癌21例临床分析 总被引:1,自引:0,他引:1
Yao-Jun Xiao Shao-Bin Zheng Wan-Long Tan Tong Chen Huan Qi Zhi-Qiang Shao Yao-Dong Jiang Peng Wu Hui-Jian Zhang 《第一军医大学学报》2005,25(3):357-359
OBJECTIVE: To evaluate the clinical effects of nephron-sparing surgery in patients with early-stage small renal cell carcinoma. METHODS: Nephron-sparing surgery was performed in 21 patients with renal cell carcinoma including 1 with solitary kidney, 3 with unilateral tumor and contralateral renal compromise, and 17 with unilateral tumor and normal contralateral kidney. The diameter of the tumors ranged from 1.5 to 6.0 cm, with a mean of 2.8 cm. The tumor diameter in 17 patients with normal contralateral kidney was less than 4 cm (mean 2.5 cm) and the average diameter in 4 patients with contralateral renal compromise was 4.2 cm. Sixteen cases were in stage T(1), 4 in stage T(2), and 1 in stage T(3). Of the 21 patients, 4 underwent tumor enucleation, 10 polar nephrectomy and 7 wedge resection. RESULTS: All patients were followed up for an average of 40.8 months (7 to 66 months). One patient suffered a right lung and mediastinum metastasis 3 years after the surgery later and 1 with chronic glomerulonephritis required dialysis 27 months after the operation. No surgical complication or local recurrence were found in other patients. CONCLUSION: As a safe and effective therapy for early-stage small renal cell carcinoma, nephron-sparing surgery can be considered as the gold-standard therapy for patients with lesions less than 4 cm in T(1) and T(2) stages of localized unilateral tumor with normal contralateral kidney. 相似文献